Orbimed Advisors LLC Pmv Pharmaceuticals, Inc. Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
A detailed history of Orbimed Advisors LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 6,475,291 shares of PMVP stock, worth $9.13 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
6,475,291
Previous 6,475,291
-0.0%
Holding current value
$9.13 Million
Previous $9.65 Million
1.34%
% of portfolio
0.26%
Previous 0.23%
Shares
4 transactions
Others Institutions Holding PMVP
# of Institutions
78Shares Held
41.8MCall Options Held
500Put Options Held
500-
Sio Capital Management, LLC New York, NY3.57MShares$5.04 Million2.01% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.51MShares$4.95 Million0.08% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.47MShares$4.89 Million3.25% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.7 Million0.54% of portfolio
-
Alkeon Capital Management LLC New York, NY2.34MShares$3.3 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $64.3M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...